West African residents have frequent opportunities for exposure to the hepatitis C virus, according to a comprehensive review in the journal PLOS ONE co-authored by infectious disease specialist Jennifer Layden, MD, PhD of ...
Feb 1, 2016
0
0
(HealthDay)—For patients with stage 4 or 5 chronic kidney disease and hepatitis C virus (HCV) infection, 12 weeks of treatment with glecaprevir and pibrentasvir results in a high rate of sustained virologic response, according ...
Oct 12, 2017
0
0
Hepatitis C is caused by a highly infectious virus affecting millions across the globe and can lead to a variety of liver ailments. While the hepatitis C virus (HCV) can sometimes be fought off and cleared by the immune system ...
Dec 6, 2017
0
0
In a 10 year span, more than 130,000 patients were notified of medical errors that may have exposed them to blood-borne illness, including Hepatitis C. However, the majority of these notification events were discovered only ...
May 23, 2018
0
6
The American Gastroenterological Association (AGA) Clinical Decision Tool for the Screening and Evaluation of Hepatitis C (HCV) will help gastroenterologists in the early management of HCV-positive patients, according to ...
Nov 5, 2013
0
0
Physicians are encountering a growing number of younger patients who are testing positive for hepatitis C virus (HCV) fueled largely by the opioid crisis impacting communities around the country. That increase and more effective ...
Oct 17, 2018
0
0
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques ...
Apr 10, 2018
0
2
The results of the first real-world studies assessing the effectiveness and safety of glecaprevir/pibrentasvir (G/P) in patients with chronic hepatitis C virus (HCV) infection have confirmed high rates of viral suppression ...
Apr 12, 2018
0
1
Two presentations given this week at The International Liver Congress 2018 in Paris, France illustrate the impact that DAAs can have in averting HCV-related liver disease, and reducing the clinical and economic burden of ...
Apr 12, 2018
0
1
The University of Surrey has created a new mathematical model that details how the Hepatitis C (HCV) infection develops and behaves more accurately than previous models. This new model has the potential to improve treatment ...
May 29, 2018
0
1
